Formulation and evaluation of piroxicam suppositories

Authors

  • Mosbah. A. El-Majri Department of Pharmaceutical Industry, Faculty of Pharmacy, AlFateh medical University, Tripoli city, Libya
  • Rakesh kumar Sharma Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, AL-Mergeb University, AL-khooms, Libya

Keywords:

Piroxicam, In vitro evaluation, Macromelting range, Water soluble bases, Suppositories

Abstract

Piroxicam suppositories were prepared by using water soluble and oil soluble suppository bases. All the prepared suppositories were evaluated for various physical parameters like weight variation, drug content and hardness, melting point, disintegration and macromelting range. Invitro release study was performed USP type I apparatus using Sorensen's phosphate buffer pH 7.4 as dissolution media. The suppositories prepared with water soluble bases were within permissible range of all physical parameters. In vitro drug released from water soluble bases (hydrous PEG and anhydrous PEG) was greater than that from oil soluble bases.

References

Goodman DO. Pharmacokinetics: Disposition and

metabolism of drugs. In: Munson PL, Muller RA,

Breese GR. editors. principles of pharmacology.

st ed. New York: Chapman and Hall; 2001. p. 47

Sanyal P, Roy G. Preparation and evaluation of

suppositories of paracetamol. East Pharma 2001;

:95-7.

Nair L, Bhargava HN. Comparison of in vitro

dissolution and permeation of fluconazole from

different suppository bases. Drug Develop Ind

Pharm1999; 25:691

Akala EO, Adedoyn A, Ogunbona FA.

Suppository formulations of amodiaquine: In vitro

release characteristics. Drug Develop Ind Pharm

;17: 303-7

Borne RF. Nonsteroidal anti-inflammatory agents.

In: Williams AD, Lemke LT, editors. Foye's

principle of medicinal chemistry. 5th ed.

Lippincot William and Wilkins; 2002. p. 751-93.

Guttadauria, M. The clinical pharmacology of

piroxicam. Acta Obstet. Gynecol. Scand. Suppl.,

, 138:11-13.

Lippincotf's Illustrated Reviews: Pharmacology,

Second Edition. by Mary J . Mycek, Richard A.

Harvey and Pamela C. Champe. Lippincott -

Raven Publishers, Philadelphia, PA O 1997 page

Suleiman MS, Najib NM. Release of

indomethacin from suppository bases. Drug

Develop Ind Pharm 1990;16:707-17.

The British pharmacopeia,The Pharm. Press.

London. 350, 624(1993).

Coben LJ, Herbert A. Lieberman eds In: Theory

and practice of Industrial Pharmacy, Varghese

publishing house, Bombay, p 585-87.

C J de Blaey, J J Tukker eds In: Michael E.

Aulton’s Pharmaceutics the science of dosage

form design Churchill livingstone 1988, p 418-19.

Gold M, Nepuri M, Lawrence H. Suppository

development and production. In: Liberman HA,

Riger MM, Banker GS, editors. Pharmaceutical

dosage forms: Disperse system. Vol. 2. 2nd ed.

New York: Marcel Dekker Inc; 1996. p. 473.

S. Verheyen. Mechanism of increased dissolution

of diazepam and temazepam from polyethylene

glycol 6000 solid dispersions. Int. J Pharm. 2002;

: 45-58.

S. Riegelman, and W.L. Chiou, "Increasing the

Absorption Rate of Insoluble Drugs," US Patent

, 1978.

Betageri G.V., Makarla K.R.. Enhancement of

dissolution of glyburide by solid dispersion and

lyophilization techniques. Int. J Pharm.1995; 126:

-160

Downloads

Published

2010-06-30

How to Cite

Mosbah. A. El-Majri, & Rakesh kumar Sharma. (2010). Formulation and evaluation of piroxicam suppositories. International Journal of Drug Delivery, 2(2), 108–112. Retrieved from https://ijdd.arjournals.org/index.php/ijdd/article/view/19

Issue

Section

Original Research Articles